{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:54:12Z","timestamp":1775188452746,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A102065"],"award-info":[{"award-number":["A102065"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00380-019-01421-1","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:27:29Z","timestamp":1557160049000},"page":"1758-1768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness"],"prefix":"10.1007","volume":"34","author":[{"given":"Sangmo","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munsuk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertis B.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seihyun","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwanwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungtaek","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dooman","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyoung","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-6780","authenticated-orcid":false,"given":"Yongsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.2337\/dc18-S009","volume":"41","author":"A American Diabetes","year":"2018","unstructured":"American Diabetes A (2018) 9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 41:S86\u2013S104","journal-title":"Diabetes Care"},{"key":"1421_CR2","doi-asserted-by":"crossref","unstructured":"Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R, Prevention of Progression of Arterial D, Diabetes Study G, Diabetes Registry G, Royal College of Physicians E (2008) The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:a1840","DOI":"10.1136\/bmj.a1840"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehm248","volume":"28","author":"A Nicolucci","year":"2007","unstructured":"Nicolucci A, De Berardis G, Sacco M, Tognoni G (2007) AHA\/ADA vs. ESC\/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J 28:1925\u20131927","journal-title":"Eur Heart J"},{"key":"1421_CR4","doi-asserted-by":"crossref","unstructured":"Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y, Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial I (2008) Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300:2134\u20132141","DOI":"10.1001\/jama.2008.623"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"C Antithrombotic Trialists","year":"2002","unstructured":"Antithrombotic Trialists C (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"issue":"7","key":"1421_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/CIRCULATIONAHA.116.025760","volume":"135","author":"Yoshihiko Saito","year":"2017","unstructured":"Saito Y, Okada S, Ogawa H, Soejima H, Sakuma M, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Morimoto T, Investigators JT (2017) Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial. Circulation 135:659\u2013670","journal-title":"Circulation"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"e44476","DOI":"10.1371\/journal.pone.0044476","volume":"7","author":"Y Kawanabe","year":"2012","unstructured":"Kawanabe Y, Takahashi M, Jin X, Abdul-Majeed S, Nauli AM, Sari Y, Nauli SM (2012) Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation. PLoS ONE 7:e44476","journal-title":"PLoS ONE"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00125-001-0740-2","volume":"45","author":"T Shinoda-Tagawa","year":"2002","unstructured":"Shinoda-Tagawa T, Yamasaki Y, Yoshida S, Kajimoto Y, Tsujino T, Hakui N, Matsumoto M, Hori M (2002) A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes. Diabetologia 45:188\u2013194","journal-title":"Diabetologia"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0168-8227(00)00235-7","volume":"52","author":"CW Ahn","year":"2001","unstructured":"Ahn CW, Lee HC, Park SW, Song YD, Huh KB, Oh SJ, Kim YS, Choi YK, Kim JM, Lee TH (2001) Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 52:45\u201353","journal-title":"Diabetes Res Clin Pract"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","volume":"98","author":"DL Dawson","year":"1998","unstructured":"Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr (1998) Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678\u2013686","journal-title":"Circulation"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1161\/CIRCULATIONAHA.109.892414","volume":"121","author":"N Katakami","year":"2010","unstructured":"Katakami N, Kim YS, Kawamori R, Yamasaki Y (2010) The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation 121:2584\u20132591","journal-title":"Circulation"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000135654","volume":"26","author":"Y Shinohara","year":"2008","unstructured":"Shinohara Y, Gotoh F, Tohgi H, Hirai S, Terashi A, Fukuuchi Y, Otomo E, Itoh E, Matsuda T, Sawada T, Yamaguchi T, Nishimaru K, Ohashi Y (2008) Antiplatelet cilostazol is beneficial in diabetic and\/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. Cerebrovasc Dis 26:63\u201370","journal-title":"Cerebrovasc Dis"},{"key":"1421_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.ATV.14.2.261","volume":"14","author":"J Persson","year":"1994","unstructured":"Persson J, Formgren J, Israelsson B, Berglund G (1994) Ultrasound-determined intima-media thickness and atherosclerosis Direct and indirect validation. Arterioscler Thromb 14:261\u2013264","journal-title":"Arterioscler Thromb"},{"key":"1421_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/oxfordjournals.aje.a116078","volume":"134","author":"G Heiss","year":"1991","unstructured":"Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C (1991) Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 134:250\u2013256","journal-title":"Am J Epidemiol"},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2796.1991.tb00336.x","volume":"229","author":"R Salonen","year":"1991","unstructured":"Salonen R, Salonen JT (1991) Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 229:225\u2013231","journal-title":"J Intern Med"},{"key":"1421_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4093\/dmj.2011.35.5.504","volume":"35","author":"SY Rhee","year":"2011","unstructured":"Rhee SY, Chon S, Kwon MK, Park Ie B, Ahn KJ, Kim IJ, Kim SH, Lee HW, Koh KS, Kim DM, Baik SH, Lee KW, Nam MS, Park YS, Woo JT, Kim YS (2011) Prevalence of chronic complications in korean patients with type 2 diabetes mellitus based on the korean national diabetes program. Diabetes Metab J 35:504\u2013512","journal-title":"Diabetes Metab J"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"e0148630","DOI":"10.1371\/journal.pone.0148630","volume":"11","author":"SY Rhee","year":"2016","unstructured":"Rhee SY, Hong SM, Chon S, Ahn KJ, Kim SH, Baik SH, Park YS, Nam MS, Lee KW, Woo JT, Kim YS (2016) Hypoglycemia and medical expenses in patients with type 2 diabetes mellitus: an analysis based on the Korea national diabetes program cohort. PLoS ONE 11:e0148630","journal-title":"PLoS ONE"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1161\/01.CIR.96.11.3849","volume":"96","author":"L Chambless","year":"1997","unstructured":"Chambless L, Keil U, Dobson A, Mahonen M, Kuulasmaa K, Rajakangas AM, Lowel H, Tunstall-Pedoe H (1997) Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985\u20131990. Multinational MONItoring of trends and determinants in Cardiovascular Disease. Circulation 96:3849\u20133859","journal-title":"Circulation"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0049-3848(99)00168-1","volume":"97","author":"M Kodama","year":"2000","unstructured":"Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y, Kosugi K, Ueda N, Hori M (2000) Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res 97:239\u2013245","journal-title":"Thromb Res"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329\u20131340","journal-title":"Lancet"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229\u2013234","journal-title":"N Engl J Med"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"1900410","DOI":"10.1109\/JTEHM.2015.2450735","volume":"3","author":"CP Loizou","year":"2015","unstructured":"Loizou CP, Nicolaides A, Kyriacou E, Georghiou N, Griffin M, Pattichis CS (2015) A comparison of ultrasound intima-media thickness measurements of the left and right common carotid artery. IEEE J Transl Eng Health Med 3:1900410","journal-title":"IEEE J Transl Eng Health Med"},{"key":"1421_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.crad.2010.12.002","volume":"66","author":"X Luo","year":"2011","unstructured":"Luo X, Yang Y, Cao T, Li Z (2011) Differences in left and right carotid intima-media thickness and the associated risk factors. Clin Radiol 66:393\u2013398","journal-title":"Clin Radiol"},{"key":"1421_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0003319710379109","volume":"62","author":"SW Lee","year":"2011","unstructured":"Lee SW, Hai JJ, Kong SL, Lam YM, Lam S, Chan PH, Chan KW, Wong KL, Tam CC, Chan RH (2011) Side differences of carotid intima-media thickness in predicting cardiovascular events among patients with coronary artery disease. Angiology 62:231\u2013236","journal-title":"Angiology"},{"key":"1421_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0895-4356(97)00059-0","volume":"50","author":"ML Bots","year":"1997","unstructured":"Bots ML, de Jong PT, Hofman A, Grobbee DE (1997) Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. J Clin Epidemiol 50:801\u2013807","journal-title":"J Clin Epidemiol"},{"key":"1421_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1600-0404.2007.00828.x","volume":"115","author":"Y Arbel","year":"2007","unstructured":"Arbel Y, Maharshak N, Gal-Oz A, Shapira I, Berliner S, Bornstein NM (2007) Lack of difference in the intimal medial thickness between the left and right carotid arteries in the young. Acta Neurol Scand 115:409\u2013412","journal-title":"Acta Neurol Scand"},{"key":"1421_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ijs.12384","volume":"10","author":"JS Jeng","year":"2015","unstructured":"Jeng JS, Sun Y, Lee JT, Lin RT, Chen CH, Po HL, Lin HJ, Liu CH, Sun MH, Sun MC, Chern CM, Lien LM, Chiu HC, Hu HH, Chiou HY, Chen ST, Ma H, Hsu CY, Investigators SS (2015) The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial. Int J Stroke 10:123\u2013127","journal-title":"Int J Stroke"},{"key":"1421_CR28","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1161\/01.ATV.18.12.1942","volume":"18","author":"MB Elam","year":"1998","unstructured":"Elam MB, Heckman J, Crouse JR, Hunninghake DB, Herd JA, Davidson M, Gordon IL, Bortey EB, Forbes WP (1998) Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler Thromb Vasc Biol 18:1942\u20131947","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1421_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2003.08.017","volume":"171","author":"T Wang","year":"2003","unstructured":"Wang T, Elam MB, Forbes WP, Zhong J, Nakajima K (2003) Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication. Atherosclerosis 171:337\u2013342","journal-title":"Atherosclerosis"},{"key":"1421_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","volume":"25","author":"JA Sugden","year":"2008","unstructured":"Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD (2008) Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25:320\u2013325","journal-title":"Diabet Med"},{"key":"1421_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2006060573","volume":"18","author":"GM London","year":"2007","unstructured":"London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613\u2013620","journal-title":"J Am Soc Nephrol"},{"key":"1421_CR32","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1210\/jc.2008-1212","volume":"94","author":"O Tarcin","year":"2009","unstructured":"Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S (2009) Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 94:4023\u20134030","journal-title":"J Clin Endocrinol Metab"},{"key":"1421_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.amjmed.2009.09.024","volume":"123","author":"DT Ngo","year":"2010","unstructured":"Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD (2010) Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 123:335\u2013341","journal-title":"Am J Med"},{"key":"1421_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.110.160929","volume":"57","author":"KL Jablonski","year":"2011","unstructured":"Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57:63\u201369","journal-title":"Hypertension"},{"key":"1421_CR35","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/j.1532-5415.2009.02359.x","volume":"57","author":"AA Ginde","year":"2009","unstructured":"Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57:1595\u20131603","journal-title":"J Am Geriatr Soc"},{"key":"1421_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ejcn.2009.140","volume":"64","author":"RD Semba","year":"2010","unstructured":"Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM, Ferrucci L (2010) Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64:203\u2013209","journal-title":"Eur J Clin Nutr"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01421-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:26:29Z","timestamp":1588634789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01421-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01421-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflict of interest relevant to this article was reported. This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). Clinical Trial Registration Number: NCT00886574.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}